Latest filing published 23 Aug 2010 for MABVAX THERAPEUTICS HOLDINGS, INC., €3,419.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Edward W. Cantrall: trading record in brief
This profile gathers the share dealings of Edward W. Cantrall in Mabvax Therapeutics Holdings, Inc. The record holds 7 filings, for trades running from 16 December 2008 to 23 August 2010.
The open-market record is one-sided, with 7 purchases worth €13k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2010, the count stands at 6 purchases and no sales.
Half of the purchases are above €881 and half below.
The newest entry dates from 23 August 2010: an open-market purchase of €3,419, in Mabvax Therapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward W. Cantrall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ US$0.72Common StockSEC:0001222083-10-000006:0Canonical exit: 21 Nov 2010 (T+90)
- 1,400 shares@ US$0.72Common StockSEC:0001222083-10-000004:0Canonical exit: 8 Sept 2010 (T+90)
- 6,475 shares@ US$0.73Common StockSEC:0001222083-10-000004:1Canonical exit: 8 Sept 2010 (T+90)
- 1,525 shares@ US$0.70Common StockSEC:0001222083-10-000004:2Canonical exit: 8 Sept 2010 (T+90)
- 400 shares@ US$0.7101Common StockSEC:0001222083-10-000004:3Canonical exit: 8 Sept 2010 (T+90)
- 200 shares@ US$0.7199Common StockSEC:0001222083-10-000004:4Canonical exit: 8 Sept 2010 (T+90)
- 20,000 shares@ US$0.28Common StockSEC:0001222083-08-000004:0Canonical exit: 16 Mar 2009 (T+90)
7 of 7 declarations